Small Pharma Expands Potential of Commercial Portfolio
Lead DMT-assisted therapy candidate SPL026’s clinical development program strengthened with the addition of two clinical trials planned for 2022 SPL028, a...
Source: globenewswire.com
Page 25 - Small Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Small Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Small Pharma Today - Breaking & Trending Today
Small Pharma to Participate in the 34th Annual Roth
Presentation to be webcast on Monday, March 14 at 3:30 – 3:55PM/PT...
Source: globenewswire.com
Small Pharma to Participate in the 34th Annual Roth Conference
Presentation to be webcast on Monday, March 14 at 3:30 – 3:55PM/PTLONDON, March 09, 2022 -- Small Pharma Inc. , a neuroscience company focused on psychedelic-assisted therapies for mental... | March 9, 2022
Source: marketscreener.com
Data from first DMT-assisted clinical trial revealed
No sign of significant negative effects on anxiety and wellbeing following pioneering Small Pharma trial - News - PharmaTimes
Source: pharmatimes.com
Small Pharma Inc.: World's First Clinical Trial For DMT-Assisted Therapy in Major Depressive Disorder Shows Consistent Quality of Psychedelic Response in Phase I
In the Phase I clinical trial, participants were administered SPL026 and underwent a 20-minute psychedelic experience Phase I full dataset demonstrates consistent dose related effects on the intensity
Source: finanznachrichten.de